-
Product Insights
NewApolipoprotein B – Drugs In Development, 2024
The Apolipoprotein B pipeline drugs market research report outlays comprehensive information on the Apolipoprotein B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Immunology, Central Nervous System, and Gastrointestinal which include indications of Aortic Valve Stenosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis, Ulcerative Colitis, and Crohn's Disease (Regional Enteritis). It also reviews key players involved...
-
Product Insights
NewAurora Kinase B – Drugs In Development, 2024
The Aurora Kinase B pipeline drugs market research report outlays comprehensive information on the Aurora Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Gastric Cancer. It also reviews key players involved in Aurora Kinase B targeted therapeutics development with respective active and...
-
Product Insights
NewComplement Factor B – Drugs In Development, 2024
The Complement Factor B pipeline drugs market research report outlays comprehensive information on the Complement Factor B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Genito Urinary System, Ophthalmology, and Hematological Disorders which include indications of Unspecified Immunological Disorders, Lupus Nephritis, IgA Nephropathy (Berger's Disease), Glomerulonephritis, Geographic Atrophy, Ocular Inflammation, Paroxysmal Nocturnal Hemoglobinuria, and Acquired (Autoimmune)...
-
Product Insights
NewProtein Kinase B – Drugs In Development, 2024
The Protein Kinase B pipeline drugs market research report outlays comprehensive information on the Protein Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Cardiovascular, Acute Ischemic Stroke, Parkinson's Disease, Unspecified Neurologic Disorders, Tuberculosis, and Coronavirus Disease 2019...
-
Product Insights
NewEndothelin B Receptor – Drugs In Development, 2024
The Endothelin B Receptor pipeline drugs market research report outlays comprehensive information on the Endothelin B Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Central Nervous System, and Ophthalmology which include indications of Glioblastoma Multiforme (GBM), Ovarian Cancer, Pulmonary Arterial Hypertension, Acute Ischemic Stroke, Alzheimer's Disease, Hypoxic-Ischemic Encephalopathy, and Diabetic Retinopathy. It also reviews...
-
Product Insights
NewB And T Lymphocyte Attenuator – Drugs In Development, 2024
The B And T Lymphocyte Attenuator pipeline drugs market research report outlays comprehensive information on the B And T Lymphocyte Attenuator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, and Dermatology which include indications of Graft Versus Host Disease (GVHD), Autoimmune Disorders, Solid Tumor, Renal Cell Carcinoma, and Atopic Dermatitis (Atopic Eczema). It also reviews...
-
Product Insights
NewB Lymphocyte Antigen CD19 – Drugs In Development, 2024
The B Lymphocyte Antigen CD19 pipeline drugs market research report outlays comprehensive information on the B Lymphocyte Antigen CD19 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Undisclosed, and Hematological Disorders which include indications of B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), Diffuse Large B-Cell Lymphoma, Autoimmune Disorders, Systemic Lupus Erythematosus, Unspecified, Acquired (Autoimmune)...
-
Product Insights
NewB Lymphocyte Antigen CD20 – Drugs In Development, 2024
The B Lymphocyte Antigen CD20 pipeline drugs market research report outlays comprehensive information on the B Lymphocyte Antigen CD20 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Genito Urinary System which include indications of Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gene Therapy To Target CD19 And CD22 For B-Cell Acute Lymphoblastic Leukemia And Lymphoma in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gene Therapy To Target CD19 And CD22 For B-Cell Acute Lymphoblastic Leukemia And Lymphoma in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ThisCART19A in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ThisCART19A in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ThisCART19A in B-Cell Acute Lymphocytic...